Drug Approval Decision Times, International Reference Pricing and Strategic Launches of New Drugs
Year of publication: |
2014
|
---|---|
Authors: | Houy, Nicolas |
Other Persons: | Jelovac, Izabela (contributor) |
Publisher: |
[2014]: [S.l.] : SSRN |
Subject: | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law | Preismanagement | Pricing strategy |
Extent: | 1 Online-Ressource (33 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments October 8, 2014 erstellt |
Other identifiers: | 10.2139/ssrn.2507201 [DOI] |
Classification: | I11 - Analysis of Health Care Markets ; L65 - Chemicals; Rubber; Drugs; Biotechnology |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Bargaining and International Reference Pricing in the Pharmaceutical Industry
Dubois, Pierre, (2022)
-
Does increased price competition reduce entry of new pharmaceutical products?
Granlund, David, (2011)
-
Pricing and Reimbursement in U.S. Pharmaceutical Markets
Berndt, Ernst R., (2010)
- More ...
-
Drug launch timing and international reference pricing
Houy, Nicolas, (2013)
-
Drug approval decision times, international reference pricing and strategic launches of new drugs
Houy, Nicolas, (2014)
-
Drug approval decision times, international reference pricing and strategic launches of new drugs
Houy, Nicolas, (2014)
- More ...